BET1L, RAD50, ANXA1 and AURKA are prognostic biomarkers in ICC patients. The prognostic model has high prognostic accuracy. High expression of BET1L indicates poor prognosis of ICC patients. Low expression of BET1L inhibited the proliferation of HUCCT1 cells.
Yin et al. (Sun,) studied this question.